301
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson’s disease

, , &
Pages 1543-1552 | Accepted 16 Mar 2010, Published online: 30 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

András Salamon, Dénes Zádori, László Szpisjak, Péter Klivényi & László Vécsei. (2020) Fixed-dose combination therapy for Parkinson’s disease with a spotlight on entacapone in the past 20 years: a reduced pill burden and a simplified dosing regime. Expert Opinion on Pharmacotherapy 21:18, pages 2265-2278.
Read now
Thomas Müller. (2020) Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson’s disease. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 403-414.
Read now
Zhan-Miao Yi, Ting-Ting Qiu, Yuan Zhang, Na Liu & Suo-Di Zhai. (2018) Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson’s disease: systematic review, meta-analysis, and economic evaluation. Therapeutics and Clinical Risk Management 14, pages 709-719.
Read now

Articles from other publishers (4)

Qiran Wei, Jiting Zhou, Hongchao Li, Luying Wang, Yao Wu, Aixia Ma & Xin Guan. (2023) Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Nabila Dahodwala, Jordan Jahnke, Amy R. Pettit, Pengxiang Li, Vrushabh P. Ladage, Prasanna L. Kandukuri, Yanjun Bao, Jorge Zamudio, Yash J. Jalundhwala & Jalpa A. Doshi. (2021) Low Sustainment of High-Dose Oral Medication Regimens for Advanced Parkinson’s Disease in Medicare Beneficiaries. Journal of Parkinson's Disease 11:2, pages 675-684.
Crossref
Ronald F. Pfeiffer. 2013. Handbook of Parkinson’s Disease. Handbook of Parkinson’s Disease 448 465 .
. (2011) Current World Literature. Current Opinion in Cardiology 26:4, pages 356-361.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.